Smruthi Organics Share Price
Sector: Biotechnology & Drugs
130.00 +2.65 (2.08%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
128.65
Today’s High
131.95
52 Week Low
103.00
52 Week High
182.45
Key Metrics
- Market Cap (In Cr) 146.9
- Beta 1.2
- Div. Yield (%) 1.18
- P/B 2.04
- TTM P/E 35.21
- Peg Ratio -1.36
- Sector P/E 24.28
- D/E 0
- Open Price 130.8
- Prev Close 127.7
Smruthi Organics Analysis
Price Analysis
-
1 Week-2.71%
-
3 Months3.87%
-
6 Month-0.59%
-
YTD6.35%
-
1 Year-20.7%
Risk Meter
- 48% Low risk
- 48% Moderate risk
- 48% Balanced Risk
- 48% High risk
- 48% Extreme risk
Smruthi Organics Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 126.01
- Selling/ General/ Admin Expenses Total
- 28.54
- Depreciation/ Amortization
- 5.5
- Other Operating Expenses Total
- 1.83
- Total Operating Expense
- 119.34
- Operating Income
- 6.66
- Net Income Before Taxes
- 4.9
- Net Income
- 3.56
- Diluted Normalized EPS
- 3.11
- Period
- 2025
- Total Assets
- 111.74
- Total Liabilities
- 40.11
- Total Equity
- 71.63
- Tangible Book Valueper Share Common Eq
- 62.44
- Period
- 2025
- Cashfrom Operating Activities
- 9.98
- Cashfrom Investing Activities
- -11.42
- Cashfrom Financing Activities
- 1.4
- Net Changein Cash
- -0.04
- Period
- 2024
- Total Revenue
- 127.64
- Selling/ General/ Admin Expenses Total
- 27.41
- Depreciation/ Amortization
- 5.35
- Other Operating Expenses Total
- 2.44
- Total Operating Expense
- 121.15
- Operating Income
- 6.49
- Net Income Before Taxes
- 4.97
- Net Income
- 3.59
- Diluted Normalized EPS
- 3.33
- Period
- 2024
- Total Assets
- 118.19
- Total Liabilities
- 48.57
- Total Equity
- 69.62
- Tangible Book Valueper Share Common Eq
- 60.67
- Period
- 2024
- Cashfrom Operating Activities
- 4.4
- Cashfrom Investing Activities
- -7.16
- Cashfrom Financing Activities
- 2.66
- Net Changein Cash
- -0.11
- Period
- 2023
- Total Revenue
- 141.04
- Selling/ General/ Admin Expenses Total
- 27.5
- Depreciation/ Amortization
- 4.57
- Total Operating Expense
- 135.7
- Operating Income
- 5.34
- Net Income Before Taxes
- 4.49
- Net Income
- 4.13
- Diluted Normalized EPS
- 3.61
- Period
- 2023
- Total Assets
- 105.64
- Total Liabilities
- 37.48
- Total Equity
- 68.16
- Tangible Book Valueper Share Common Eq
- 59.47
- Period
- 2023
- Cashfrom Operating Activities
- 12.11
- Cashfrom Investing Activities
- -10.25
- Cashfrom Financing Activities
- -1.52
- Net Changein Cash
- 0.34
- Period
- 2022
- Total Revenue
- 133.37
- Selling/ General/ Admin Expenses Total
- 13.73
- Depreciation/ Amortization
- 4.26
- Other Operating Expenses Total
- 21.15
- Total Operating Expense
- 119.2
- Operating Income
- 14.17
- Net Income Before Taxes
- 13.77
- Net Income
- 10.38
- Diluted Normalized EPS
- 9.07
- Period
- 2022
- Total Assets
- 87.61
- Total Liabilities
- 20.45
- Total Equity
- 67.16
- Tangible Book Valueper Share Common Eq
- 58.68
- Period
- 2022
- Cashfrom Operating Activities
- 2.17
- Cashfrom Investing Activities
- 7.15
- Cashfrom Financing Activities
- -12.11
- Net Changein Cash
- -2.79
- Period
- 2021
- Total Revenue
- 126.5
- Selling/ General/ Admin Expenses Total
- 15.64
- Depreciation/ Amortization
- 3.95
- Other Operating Expenses Total
- 15.87
- Total Operating Expense
- 101.91
- Operating Income
- 24.59
- Net Income Before Taxes
- 24.06
- Net Income
- 17.11
- Diluted Normalized EPS
- 14.95
- Period
- 2021
- Total Assets
- 91.82
- Total Liabilities
- 31.33
- Total Equity
- 60.49
- Tangible Book Valueper Share Common Eq
- 52.85
- Period
- 2021
- Cashfrom Operating Activities
- 22.82
- Cashfrom Investing Activities
- -3.4
- Cashfrom Financing Activities
- -6.86
- Net Changein Cash
- 12.57
- Period
- 2020
- Total Revenue
- 131.07
- Selling/ General/ Admin Expenses Total
- 13.57
- Depreciation/ Amortization
- 4.39
- Other Operating Expenses Total
- 18.78
- Total Operating Expense
- 120.22
- Operating Income
- 10.85
- Net Income Before Taxes
- 12.09
- Net Income
- 8.45
- Diluted Normalized EPS
- 7.38
- Period
- 2020
- Total Assets
- 87.75
- Total Liabilities
- 45.29
- Total Equity
- 42.46
- Tangible Book Valueper Share Common Eq
- 37.1
- Period
- 2020
- Cashfrom Operating Activities
- 21.43
- Cashfrom Investing Activities
- -4.52
- Cashfrom Financing Activities
- -17.49
- Net Changein Cash
- -0.58
- Period
- 2025-03-31
- Total Revenue
- 38.09
- Selling/ General/ Admin Expenses Total
- 4.15
- Depreciation/ Amortization
- 1.5
- Other Operating Expenses Total
- 6.96
- Total Operating Expense
- 34.92
- Operating Income
- 3.17
- Net Income Before Taxes
- 2.73
- Net Income
- 2.23
- Diluted Normalized EPS
- 1.97
- Period
- 2025-03-31
- Total Assets
- 111.74
- Total Liabilities
- 40.11
- Total Equity
- 71.63
- Tangible Book Valueper Share Common Eq
- 62.44
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 9.97
- Cashfrom Investing Activities
- -11.42
- Cashfrom Financing Activities
- 1.4
- Net Changein Cash
- -0.04
- Period
- 2024-12-31
- Total Revenue
- 31.25
- Selling/ General/ Admin Expenses Total
- 4.43
- Depreciation/ Amortization
- 1.37
- Other Operating Expenses Total
- 7.73
- Total Operating Expense
- 28.46
- Operating Income
- 2.79
- Net Income Before Taxes
- 2.29
- Net Income
- 1.48
- Diluted Normalized EPS
- 1.29
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 29.39
- Selling/ General/ Admin Expenses Total
- 5.12
- Depreciation/ Amortization
- 1.33
- Other Operating Expenses Total
- 6.13
- Total Operating Expense
- 27.83
- Operating Income
- 1.56
- Net Income Before Taxes
- 1.13
- Net Income
- 0.78
- Diluted Normalized EPS
- 0.68
- Period
- 2024-09-30
- Total Assets
- 107.51
- Total Liabilities
- 39.73
- Total Equity
- 67.78
- Tangible Book Valueper Share Common Eq
- 59.07
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 4.66
- Cashfrom Investing Activities
- -7.05
- Cashfrom Financing Activities
- 2.56
- Net Changein Cash
- 0.17
- Period
- 2024-06-30
- Total Revenue
- 27.27
- Selling/ General/ Admin Expenses Total
- 3.65
- Depreciation/ Amortization
- 1.29
- Other Operating Expenses Total
- 7.05
- Total Operating Expense
- 28.12
- Operating Income
- -0.85
- Net Income Before Taxes
- -1.25
- Net Income
- -0.92
- Diluted Normalized EPS
- -0.81
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 39.66
- Selling/ General/ Admin Expenses Total
- 4.29
- Depreciation/ Amortization
- 1.59
- Other Operating Expenses Total
- 6.87
- Total Operating Expense
- 37.16
- Operating Income
- 2.5
- Net Income Before Taxes
- 2.19
- Net Income
- 1.52
- Diluted Normalized EPS
- 1.33
- Period
- 2024-03-31
- Total Assets
- 118.19
- Total Liabilities
- 48.57
- Total Equity
- 69.62
- Tangible Book Valueper Share Common Eq
- 60.67
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 4.4
- Cashfrom Investing Activities
- -7.16
- Cashfrom Financing Activities
- 2.66
- Net Changein Cash
- -0.11
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Smruthi Organics Technical
Moving Average
SMA
- 5 Day129.43
- 10 Day131.59
- 20 Day129.23
- 50 Day121.34
- 100 Day124.16
- 300 Day129.68
Smruthi Organics Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Aarey Drugs & Pharmaceuticals
- 55
- 0
- 0
- 75.75
- 31.3
- 155.61
- Bdh Industries
- 262.5
- 0.55
- 0.21
- 417.85
- 241
- 151.13
- Smruthi Organics
- 130
- 2.65
- 2.08
- 182.45
- 103
- 146.9
- Denis Chem Lab
- 106.95
- 1.9
- 1.81
- 232.9
- 87.99
- 148.41
- Take Solutions
- 8.9
- 0.1
- 1.14
- 23.68
- 6.7
- 131.66
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Aarey Drugs & Pharmaceuticals
- 29.99
- 1.12
- 4.42
- 1.2
- Bdh Industries
- 15.76
- 2.13
- 15.62
- 11.57
- Smruthi Organics
- 41.02
- 2.04
- 12.02
- 5.92
- Denis Chem Lab
- 17.65
- 1.67
- 10.1
- 4.76
- Take Solutions
- 173.51
- 6.23
- -29.44
- -40
Smruthi Organics Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 05-May-25
- Audited Results & Final Dividend
- 04-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 27-Jul-24
- Quarterly Results
- 06-May-24
- Audited Results & Final Dividend
- 03-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 05-Aug-23
- Quarterly Results
- 20-May-23
- Audited Results & Final Dividend
- 09-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 20-Jun-25
- 05-May-25
- AGM
- 14-Sept-24
- 29-Jul-24
- AGM
- 05-Aug-23
- 22-May-23
- AGM
- 25-Mar-22
- 21-Feb-22
- POM
- 16-Jul-21
- 09-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 05-May-25
- 13-Jun-25
- 13-Jun-25
- 1.5
- 06-May-24
- -
- 06-Sept-24
- 1.5
- 22-May-23
- -
- 28-Jul-23
- 2
- 30-May-22
- -
- 28-Jul-22
- 3
- 23-Apr-21
- -
- 01-Jul-21
- 3
- Announced on
- Record Date
- Ex-Bonus
- Description
- 16-Jan-21
- 17-Mar-21
- 16-Mar-21
- Bonus issue in the ratio of 2:1 of Rs. 10/-.

